Droxidopa Capsule
Product Images NDC 70710-1389

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Droxidopa (NDC 70710-1389). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (05c71afa 5724 46ea B841 Eb124e2e4130 01)

Chemical structure of droxidopa showing its molecular arrangement including a benzene ring with hydroxyl groups, an amino group, and a carboxylic acid group. This chemical structure represents the active ingredient droxidopa in the oral capsule dosage form by Zydus Pharmaceuticals USA Inc.*

FDA Label Image

Image (05c71afa 5724 46ea B841 Eb124e2e4130 02)

A line graph showing mean change in dizziness over an 8-week double-blind treatment phase. Two groups are compared: Droxidopa (solid line) and Placebo (dashed line). The y-axis measures mean change in dizziness, and the x-axis represents weeks. Droxidopa shows a greater reduction in dizziness starting at week 1, with statistical significance indicated (p<0.05). Error bars are present for each data point.*

FDA Label Image

Image (05c71afa 5724 46ea B841 Eb124e2e4130 03)

A bar chart comparing percent of subjects reporting improvement in OHSA Question 1 between Droxidopa and Placebo groups. The x-axis shows improvement scores from -8 (worse) to 8 (better), and the y-axis shows the percentage of subjects. Black bars represent Droxidopa; white bars represent Placebo. The data illustrate distribution of improvements with varying scores for both groups.*

FDA Label Image

Image (05c71afa 5724 46ea B841 Eb124e2e4130 04)

Box label for Droxidopa Capsules 100 mg by Zydus Pharmaceuticals USA Inc. The label states the package contains 90 oral capsules with child-resistant packaging. It includes storage instructions, directions to consult the package insert for dosage, and manufacturer details showing Cadila Healthcare Ltd., India.*

FDA Label Image

Image (05c71afa 5724 46ea B841 Eb124e2e4130 05)

Droxidopa Capsules 200 mg oral capsules label showing 90 capsules in the package. The label includes the NDC 70710-1390-9, dosage strength highlighted in orange, manufacturer information for Zydus Pharmaceuticals USA Inc., and storage instructions. It features a barcode and states the product is prescription only and child-resistant.*

FDA Label Image

Image (05c71afa 5724 46ea B841 Eb124e2e4130 06)

Droxidopa Capsules 300 mg oral capsules label showing the product name, strength, and quantity of 90 capsules. The label includes manufacturer information with Zydus Pharmaceuticals USA Inc. as the distributor. It features storage instructions, a barcode, and cautions such as child resistance and keeping the medication out of reach of children. The label also states the prescription-only status.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.